REFERENCES
1. Jankovic N, Geelen A, Streppel MT, et al. WHO guidelines for a healthy diet and mortality from cardiovascular disease in European and American elderly: the CHANCES project. Am J Clin Nutr 2015; 102: 745-756. 2015/09/12. DOI: 10.3945/ajcn.114.095117.
2. Mortality GBD and Causes of Death C. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459-1544. 2016/10/14. DOI: 10.1016/S0140-6736(16)31012-1.
3. Rafieian-Kopaei M, Setorki M, Doudi M, et al. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med2014; 5: 927-946. 2014/12/10.
4. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. The New England journal of medicine 1998; 338: 1650-1656. 1998/06/06. DOI: 10.1056/NEJM199806043382302.
5. Acarturk E, Demir M and Kanadasi M. Aortic atherosclerosis is a marker for significant coronary artery disease. Jpn Heart J 1999; 40: 775-781. 2000/03/29. DOI: 10.1536/jhj.40.775.
6. Sahadevan M, Chee KH and Tai MS. Prevalence of extracranial carotid atherosclerosis in the patients with coronary artery disease in a tertiary hospital in Malaysia. Medicine (Baltimore) 2019; 98: e15082. 2019/04/16. DOI: 10.1097/MD.0000000000015082.
7. Suh B, Song YS, Shin DW, et al. Incidentally detected atherosclerosis in the abdominal aorta or its major branches on computed tomography is highly associated with coronary heart disease in asymptomatic adults.J Cardiovasc Comput Tomogr 2018; 12: 305-311. 2018/03/27. DOI: 10.1016/j.jcct.2018.03.001.
8. Drozd J, Jargiełło T, Opalińska E, et al. Choroba naczyń wieńcowych a zmiany miażdżycowe w tętnicach szyjnych oceniane metodą biopsji ultradźwiękowej. Folia Cardiologica 2003; 10: 759–767.
9. Khoury Z, Schwartz R, Gottlieb S, et al. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997; 80: 1429-1433. 1997/12/17. DOI: 10.1016/s0002-9149(97)00701-7.
10. Aboyans V and Lacroix P. Indications for carotid screening in patients with coronary artery disease. Presse Med 2009; 38: 977-986. 2009/04/21. DOI: 10.1016/j.lpm.2009.02.015.
11. Rangel A, Albarran H, Solorio S, et al. Angiographic concurrence of coronary artery disease and aortoiliac lesions. Angiology 2002; 53: 685-692. 2002/12/05. DOI: 10.1177/000331970205300609.
12. Rigatelli G. Aortoiliac angiography during coronary artery angiography detects significant occult aortoiliac and renal artery atherosclerosis in patients with coronary atherosclerosis. Int J Cardiovasc Imaging 2004; 20: 299-303. 2004/11/09. DOI: 10.1023/b:caim.0000041948.14956.44.
13. Rigatelli G and Rigatelli G. Malpractice in invasive cardiology: is angiography of abdominal aorta or subclavian artery appropriate in patients undergoing coronary angiography? A meta analysis. Int J Cardiovasc Imaging 2005; 21: 591-598. 2005/12/03. DOI: 10.1007/s10554-005-3753-y.
14. Imori Y, Akasaka T, Ochiai T, et al. Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease. Am J Cardiol2014; 113: 30-35. DOI: 10.1016/j.amjcard.2013.09.015.
15. Puz P, Lasek-Bal A, Warsz-Wianecka A, et al. Prevalence of atherosclerotic stenosis of the carotid and cerebral arteries in patients with stable or unstable coronary artery disease. Pol Arch Intern Med 2020; 130: 412-419. 2020/05/02. DOI: 10.20452/pamw.15330.
16. Tanimoto S, Ikari Y, Tanabe K, et al. Prevalence of carotid artery stenosis in patients with coronary artery disease in Japanese population. Stroke 2005; 36: 2094-2098. 2005/09/24. DOI: 10.1161/01.STR.0000185337.82019.9e.
17. Saleh A, Makhamreh H, Qoussoos T, et al. Prevalence of previously unrecognized peripheral arterial disease in patients undergoing coronary angiography. Medicine (Baltimore) 2018; 97: e11519. 2018/07/20. DOI: 10.1097/MD.0000000000011519.
18. Park S, Jung JH, Seo HS, et al. The prevalence and clinical predictors of atherosclerotic renal artery stenosis in patients undergoing coronary angiography. Heart Vessels 2004; 19: 275-279. 2005/04/01. DOI: 10.1007/s00380-004-0789-1.
19. Makowsky MJ, McAlister FA, Galbraith PD, et al. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy. Am Heart J 2008; 155: 348-355. 2008/01/25. DOI: 10.1016/j.ahj.2007.09.005.
20. Dzielinska Z, Januszewicz A, Demkow M, et al. Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J Hypertens 2007; 25: 663-670. DOI: 10.1097/HJH.0b013e328011dc6c.
21. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-477. 2019/09/11. DOI: 10.1093/eurheartj/ehz425.
22. Steinl DC and Kaufmann BA. Ultrasound imaging for risk assessment in atherosclerosis. Int J Mol Sci 2015; 16: 9749-9769. 2015/05/06. DOI: 10.3390/ijms16059749.
23. Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, et al. Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study.Circulation 2015; 131: 2104-2113. 2015/04/18. DOI: 10.1161/CIRCULATIONAHA.114.014310.
24. Spacek M, Zemanek D, Hutyra M, et al. Vulnerable atherosclerotic plaque - a review of current concepts and advanced imaging. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018; 162: 10-17. 2018/02/23. DOI: 10.5507/bp.2018.004.
25. Steinvil A, Sadeh B, Bornstein NM, et al. Impact of carotid atherosclerosis on the risk of adverse cardiac events in patients with and without coronary disease. Stroke 2014; 45: 2311-2317. 2014/06/19. DOI: 10.1161/STROKEAHA.114.005663.
26. Vranic H, Hadzimehmedagic A, Haxibeqiri-Karabdic I, et al. Critical Carotid Artery Stenosis in Coronary and Non-Coronary Patients - Frequency of Risk Factors. Med Arch 2017; 71: 110-114. 2017/08/10. DOI: 10.5455/medarh.2017.71.110-114.
27. He J, Chen P, Luo Y, et al. Relationship between the maximum carotid plaque area and the severity of coronary atherosclerosis. Int Angiol 2018; 37: 300-309. 2018/03/10. DOI: 10.23736/S0392-9590.18.03967-6.
28. Zhu Y, You J, Xu C, et al. Predictive value of carotid artery ultrasonography for the risk of coronary artery disease. J Clin Ultrasound 2021; 49: 218-226. 2020/10/15. DOI: 10.1002/jcu.22932.
29. Morito N, Inoue Y, Urata M, et al. Increased carotid artery plaque score is an independent predictor of the presence and severity of coronary artery disease. J Cardiol 2008; 51: 25-32. 2008/06/05. DOI: 10.1016/j.jjcc.2007.09.003.
30. Kanadasi M, Cayli M, San M, et al. The presence of a calcific plaque in the common carotid artery as a predictor of coronary atherosclerosis.Angiology 2006; 57: 585-592. 2006/10/28. DOI: 10.1177/0003319706293123.
31. Bytyci I, Shenouda R, Wester P, et al. Carotid Atherosclerosis in Predicting Coronary Artery Disease: A Systematic Review and Meta-Analysis. Arterioscler Thromb Vasc Biol 2021; 41: e224-e237. 2021/02/26. DOI: 10.1161/ATVBAHA.120.315747.
32. Brook RD, Bard RL, Patel S, et al. A negative carotid plaque area test is superior to other noninvasive atherosclerosis studies for reducing the likelihood of having underlying significant coronary artery disease. Arterioscler Thromb Vasc Biol 2006; 26: 656-662. 2005/12/17. DOI: 10.1161/01.ATV.0000200079.18690.60.
33. Ikeda N, Kogame N, Iijima R, et al. Carotid artery intima-media thickness and plaque score can predict the SYNTAX score. Eur Heart J 2012; 33: 113-119. 2011/10/27. DOI: 10.1093/eurheartj/ehr399.
34. Chang CC, Chang ML, Huang CH, et al. Carotid intima-media thickness and plaque occurrence in predicting stable angiographic coronary artery disease. Clin Interv Aging 2013; 8: 1283-1288. 2013/10/08. DOI: 10.2147/CIA.S49166.
35. Akazawa S, Tojikubo M, Nakano Y, et al. Usefulness of carotid plaque (sum and maximum of plaque thickness) in combination with intima-media thickness for the detection of coronary artery disease in asymptomatic patients with diabetes. J Diabetes Investig 2016; 7: 396-403. 2016/06/23. DOI: 10.1111/jdi.12403.
36. Chung J-W. Association between Carotid Artery Plaque Score and SYNTAX Score in Coronary Artery Disease Patients. General Medicine: Open Access 2017; 5. DOI: 10.4172/2327-5146.1000301.
37. Sirimarco G, Amarenco P, Labreuche J, et al. Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis. Stroke 2013; 44: 373-379. 2013/01/12. DOI: 10.1161/STROKEAHA.112.673129.
38. Ozcaglayan O, K TI, Gur DO, et al. Carotid arteries and vertebrobasilary system intracranial stenosis correlates with multi vessel coronary artery disease. Bratisl Lek Listy 2019; 120: 362-367. 2019/05/23. DOI: 10.4149/BLL_2019_059.
39. Molnar S, Kerenyi L, Ritter MA, et al. Correlations between the atherosclerotic changes of femoral, carotid and coronary arteries: a post mortem study. J Neurol Sci 2009; 287: 241-245. 2009/08/18. DOI: 10.1016/j.jns.2009.06.001.
40. Grubic N, Colledanchise KN, Liblik K, et al. The Role of Carotid and Femoral Plaque Burden in the Diagnosis of Coronary Artery Disease.Curr Cardiol Rep 2020; 22: 121. 2020/08/12. DOI: 10.1007/s11886-020-01375-1.
41. Johri AM, Behl P, Hetu MF, et al. Carotid Ultrasound Maximum Plaque Height-A Sensitive Imaging Biomarker for the Assessment of Significant Coronary Artery Disease. Echocardiography 2016; 33: 281-289. 2015/07/01. DOI: 10.1111/echo.13007.
42. Spence JD. Ultrasound Measurement of Carotid Plaque as a Surrogate Outcome for Coronary Artery Disease. Am J Cardiol 2002; 89(suppl): 10B–16B.
43. Johri AM, Nambi V, Naqvi TZ, et al. Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography. J Am Soc Echocardiogr 2020; 33: 917-933. 2020/07/01. DOI: 10.1016/j.echo.2020.04.021.
44. Peters SA, den Ruijter HM, Bots ML, et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review. Heart 2012; 98: 177-184. 2011/11/19. DOI: 10.1136/heartjnl-2011-300747.
45. Zhao Q, Zhao X, Cai Z, et al. Correlation of coronary plaque phenotype and carotid atherosclerotic plaque composition. Am J Med Sci 2011; 342: 480-485. 2011/06/18. DOI: 10.1097/MAJ.0b013e31821caa88.
46. Bos D, Arshi B, van den Bouwhuijsen QJA, et al. Atherosclerotic Carotid Plaque Composition and Incident Stroke and Coronary Events.J Am Coll Cardiol 2021; 77: 1426-1435. 2021/03/20. DOI: 10.1016/j.jacc.2021.01.038.
47. Uematsu M, Nakamura T, Horikoshi T, et al. Echolucency of carotid plaque is useful for selecting high-risk patients with chronic coronary artery disease who benefit from intensive lipid-lowering therapy.J Cardiol 2021; 77: 590-598. 2021/01/28. DOI: 10.1016/j.jjcc.2021.01.002.
48. Nakamura J, Nakamura T, Deyama J, et al. Assessment of carotid plaque neovascularization using quantitative analysis of contrast-enhanced ultrasound imaging is useful for risk stratification in patients with coronary artery disease. Int J Cardiol 2015; 195: 113-119. 2015/05/31. DOI: 10.1016/j.ijcard.2015.05.107.
49. Jashari F, Ibrahimi P, Nicoll R, et al. Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis2013; 227: 193-200. 2012/12/12. DOI: 10.1016/j.atherosclerosis.2012.11.008.
50. Dweck MR, Puntman V, Vesey AT, et al. MR Imaging of Coronary Arteries and Plaques. JACC Cardiovasc Imaging 2016; 9: 306-316. 2016/03/12. DOI: 10.1016/j.jcmg.2015.12.003.
51. Bauersachs R, Zeymer U, Brière JB, et al. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review.Cardiovasc Ther 2019; 2019: 8295054. 2020/02/27. DOI: 10.1155/2019/8295054.
52. Aday AW and Matsushita K. Epidemiology of Peripheral Artery Disease and Polyvascular Disease. Circ Res 2021; 128: 1818-1832. 2021/06/11. DOI: 10.1161/circresaha.121.318535.
53. Cho SW, Kim BG, Kim DH, et al. Prediction of coronary artery disease in patients with lower extremity peripheral artery disease. Int Heart J 2015; 56: 209-212. 2015/03/06. DOI: 10.1536/ihj.14-284.
54. Kumar A, Bano S, Bhurgri U, et al. Peripheral Artery Disease as a Predictor of Coronary Artery Disease in Patients Undergoing Coronary Angiography. Cureus 2021; 13: e15094. 2021/06/24. DOI: 10.7759/cureus.15094.
55. Moussa ID, Jaff MR, Mehran R, et al. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv 2009; 73: 719-724. 2009/02/13. DOI: 10.1002/ccd.21969.
56. Belcaro G, Nicolaides AN, Ramaswami G, et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)).Atherosclerosis 2001; 156: 379-387. 2001/06/08. DOI: 10.1016/s0021-9150(00)00665-1.
57. Cournot M, Bura A, Cambou JP, et al. Arterial ultrasound screening as a tool for coronary risk assessment in asymptomatic men and women.Angiology 2012; 63: 282-288. 2011/08/30. DOI: 10.1177/0003319711414865.
58. Kocyigit D, Gurses KM, Taydas O, et al. Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up. J Cardiol 2020; 75: 537-543. 2019/10/21. DOI: 10.1016/j.jjcc.2019.09.012.
59. Laclaustra M, Casasnovas JA, Fernandez-Ortiz A, et al. Femoral and Carotid Subclinical Atherosclerosis Association With Risk Factors and Coronary Calcium: The AWHS Study. J Am Coll Cardiol 2016; 67: 1263-1274. 2016/03/19. DOI: 10.1016/j.jacc.2015.12.056.
60. Santoro L, Ferraro PM, Flex A, et al. New semiquantitative ultrasonographic score for peripheral arterial disease assessment and its association with cardiovascular risk factors. Hypertens Res2016; 39: 868-873. 2016/07/15. DOI: 10.1038/hr.2016.88.
61. Santoro L, Flex A, Nesci A, et al. Association between peripheral arterial disease and cardiovascular risk factors: role of ultrasonography versus ankle-brachial index. Eur Rev Med Pharmacol Sci 2018; 22: 3160-3165. 2018/06/05. DOI: 10.26355/eurrev_201805_15076.
62. Colledanchise KN, Mantella LE, Hétu MF, et al. Femoral plaque burden by ultrasound is a better indicator of significant coronary artery disease over ankle brachial index. Int J Cardiovasc Imaging 2021; 37: 2965-2973. 2021/07/10. DOI: 10.1007/s10554-021-02334-9.
63. Kafetzakis A, Kochiadakis G, Laliotis A, et al. Association of subclinical wall changes of carotid, femoral, and popliteal arteries with obstructive coronary artery disease in patients undergoing coronary angiography. Chest 2005; 128: 2538-2543. 2005/10/21. DOI: 10.1378/chest.128.4.2538.
64. Kirhmajer MV, Banfic L, Vojkovic M, et al. Correlation of femoral intima-media thickness and the severity of coronary artery disease.Angiology 2011; 62: 134-139. 2010/08/14. DOI: 10.1177/0003319710375087.
65. Srámek A, Bosch JG, Reiber JH, et al. Ultrasound assessment of atherosclerotic vessel wall changes: reproducibility of intima-media thickness measurements in carotid and femoral arteries. Invest Radiol 2000; 35: 699-706. 2001/02/24. DOI: 10.1097/00004424-200012000-00001.
66. Colledanchise KN, Mantella LE, Bullen M, et al. Combined Femoral and Carotid Plaque Burden Identifies Obstructive Coronary Artery Disease in Women. J Am Soc Echocardiogr 2020; 33: 90-100. 2019/10/15. DOI: 10.1016/j.echo.2019.07.024.
67. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. The New England journal of medicine 1992; 326: 381-386. 1992/02/06. DOI: 10.1056/NEJM199202063260605.
68. Criqui MH, McClelland RL, McDermott MM, et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2010; 56: 1506-1512. 2010/10/19. DOI: 10.1016/j.jacc.2010.04.060.
69. Gunenc Beser C, Karcaaltincaba M, Celik HH, et al. The prevalence and distribution of the atherosclerotic plaques in the abdominal aorta and its branches. Folia Morphol (Warsz) 2016; 75: 364-375. 2016/01/30. DOI: 10.5603/FM.a2016.0005.
70. Li W, Luo S, Luo J, et al. Association between abdominal aortic plaque and coronary artery disease. Clin Interv Aging 2016; 11: 683-688. 2016/06/10. DOI: 10.2147/CIA.S104425.
71. Kronzon I and Tunick PA. Aortic atherosclerotic disease and stroke.Circulation 2006; 114: 63-75. 2006/07/05. DOI: 10.1161/CIRCULATIONAHA.105.593418.
72. Meissner I, Khandheria BK, Sheps SG, et al. Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol 2004; 44: 1018-1024. 2004/09/01. DOI: 10.1016/j.jacc.2004.05.075.
73. Fazio G, Redberg R, Winslow T, et al. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol 1993; 21: 144-150.
74. Parthenakis F, Skalidis E, Simantirakis E, et al. Absence of atherosclerotic lesions in the thoracic aorta indicates absence of significant coronary artery disease. Am J Cardiol 1996; 77: 1118-1121 SERIALS SUBS JAF. 1996/05/15. DOI: 10.1016/s0002-9149(96)00146-4.
75. Davila-Roman VG, Murphy SF, Nickerson NJ, et al. Atherosclerosis of the ascending aorta is an independent predictor of long-term neurologic events and mortality. J Am Coll Cardiol 1999; 33: 1308-1316. 1999/04/08. DOI: 10.1016/s0735-1097(99)00034-0.
76. Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association.Circulation 2019; 139: e840-e878. 2019/03/12. DOI: 10.1161/CIR.0000000000000664.
77. Ollivier R, Boulmier D, Veillard D, et al. Frequency and predictors of renal artery stenosis in patients with coronary artery disease.Cardiovasc Revasc Med 2009; 10: 23-29. DOI: 10.1016/j.carrev.2008.06.003.
78. Jean WJ, al-Bitar I, Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Diagn 1994; 32: 8-10.
79. Rihal CS, Textor SC, Breen JF, et al. Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography. Mayo Clin Proc 2002; 77: 309-316. 2002/04/09. DOI: 10.4065/77.4.309.
80. Valentine RJ, Clagett GP, Miller GL, et al. The coronary risk of unsuspected renal artery stenosis. J Vasc Surg 1993; 18: 433-439; discussion 439-440. 1993/09/01.
81. Conlon PJ, Little MA, Pieper K, et al. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.Kidney Int 2001; 60: 1490-1497. DOI: 10.1046/j.1523-1755.2001.00953.x.
82. Gross CM, Kramer J, Waigand J, et al. Relation between arteriosclerosis in the coronary and renal arteries. Am J Cardiol1997; 80: 1478-1481. 1997/12/17. DOI: 10.1016/s0002-9149(97)00727-3.
83. Liang F, Hu DY, Wu MY, et al. The incidence of renal artery stenosis in the patients referred for coronary artery bypass grafting.Indian J Nephrol 2012; 22: 13-17. DOI: 10.4103/0971-4065.91181.
84. Przewłocki T, Kabłak-Ziembicka A, Tracz W, et al. Renal artery stenosis in patients with coronary artery disease. Kardiol Pol2008; 66: 856-862.
85. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 2005; 68: 293-301. DOI: 10.1111/j.1523-1755.2005.00406.x.
86. Safak E, Wilke C, Derer W, et al. Long-term follow-up of patients with atherosclerotic renal artery disease. Journal of the American Society of Hypertension : JASH 2013; 7: 24-31. 2013/01/17. DOI: 10.1016/j.jash.2012.12.001.
87. Zanoli L, Rastelli S, Marcantoni C, et al. Non-hemodynamically significant renal artery stenosis predicts cardiovascular events in persons with ischemic heart disease. Am J Nephrol 2014; 40: 468-477. DOI: 10.1159/000368913.
88. Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med 2005; 165: 207-213. DOI: 10.1001/archinte.165.2.207.
89. Griffin M, Nicolaides A, Tyllis T, et al. Carotid and femoral arterial wall changes and the prevalence of clinical cardiovascular disease. Vasc Med 2009; 14: 227-232. 2009/08/05. DOI: 10.1177/1358863x08101542.
90. Tartiere JM, Henry OF, Safar H, et al. Carotid intima-media thickness and carotid and/or iliofemoral plaques: comparison of two markers of cardiovascular risk in hypertensive patients. J Hypertens 2003; 21: 739-746. 2003/03/27. DOI: 10.1097/01.hjh.0000052494.18130.80.
91. Yerly P, Marques-Vidal P, Owlya R, et al. The atherosclerosis burden score (ABS): a convenient ultrasound-based score of peripheral atherosclerosis for coronary artery disease prediction. J Cardiovasc Transl Res 2015; 8: 138-147. 2015/03/17. DOI: 10.1007/s12265-015-9617-5.
92. Lehrke S, Egenlauf B, Steen H, et al. Prediction of coronary artery disease by a systemic atherosclerosis score index derived from whole-body MR angiography. J Cardiovasc Magn Reson 2009; 11: 36. 2009/09/19. DOI: 10.1186/1532-429X-11-36.
93. Dodge M and Movahed MR. Screening of the Abdominal Aorta During Routine Echocardiographic Examination Is Cost-effective and Leads to Increase in Statin Utilization by Detecting Subclinical Atherosclerosis.Crit Pathw Cardiol 2021; 20: 1-3. 2020/08/10. DOI: 10.1097/HPC.0000000000000237.